Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: Pathological significance in early- and late-onset breast carcinoma

Molecular Cancer

Volumn 7, Issue , 2008, Pages

  Sinha, Satyabrata ^a   Singh, Ratnesh K ^a   Alam, Neyaz ^a   Roy, Anup ^b   Roychoudhury, Susanta ^c   Panda, Chinmay Kumar ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b MEDICAL COLLEGE AND HOSPITAL   (India)

^c INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; MESSENGER RNA; ONCOPROTEIN; PROTEIN PATCHED 1; PROTEIN PHF2; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP A PROTEIN; CELL SURFACE RECEPTOR; FANCC PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; PATCHED RECEPTORS; PHF2 PROTEIN, HUMAN; XPA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER SURVIVAL; CHROMOSOME 22; CHROMOSOME 9Q; DNA REPAIR; EXON; GENE DELETION; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; MUTATIONAL ANALYSIS; PATHOGENESIS; PROGNOSIS; PROMOTER REGION; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; BREAST TUMOR; CHROMOSOME 9; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; INDIA; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; ONSET AGE; PATHOLOGY; SURVIVAL; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ERINACEIDAE;

ADULT; AGE OF ONSET; AGED; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 9; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA REPAIR; EXONS; FANCONI ANEMIA COMPLEMENTATION GROUP C PROTEIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HOMEODOMAIN PROTEINS; HUMANS; INDIA; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RECEPTORS, CELL SURFACE; SEQUENCE DELETION; SURVIVAL ANALYSIS; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

EID: 60649119851     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-7-84     Document Type: Article

References (43)

1. Sen U Sankaranarayanan R Mandal S Ramanakumar AV Parkin DM Siddiqi M Cancer patterns in eastern India: The first report of the Kolkata cancer registry Int J Cancer 2002, 100:86-91. 10.1002/ijc.10446 12115592
2. Chung M Chang HR Bland KI Wanebo HJ Younger women with breast carcinoma have a poorer prognosis than older women Cancer 1996, 77:97-103. 10.1002/ (SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3 8630946
3. Chunder N Mandal S Basu D Roy A Roychoudhury S Panda CK Deletion mapping of chromosome 1 in early onset and late onset breast tumors-a comparative study in eastern India Pathol Res Pract 2003, 199:313-321. 10.1078/0344-0338-00423 12908521
4. Chunder N Mandal S Roy A Roychoudhury S Panda CK Analysis of different deleted regions in chromosome 11 and their interrelations in early- and late-onset breast tumors: Association with cyclin D1 amplification and survival Diagn Mol Pathol 2004, 13:172-182. 10.1097/ 01.pas.0000124337.49401.0b 15322430
5. Foo CS Su D Chong CK Chng HC Tay KH Low SC Tan SM Breast cancer in young Asian women: Study on survival ANZ J Surg 2005, 75:566-572. 10.1111/ j.1445-2197.2005.03431.x 15972049
6. Sinha S Chunder N Mukherjee N Alam N Roy A Roychoudhury S Kumar Panda C Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma Ann Surg Oncol 2008, 15:1070-1080. 10.1245/s10434-007-9790-0 18239974
7. Mitelman F Mertens F Johansson B A breakpoint map of recurrent chromosomal rearrangements in human neoplasia Nat Genet 1997, 15(Spec No):417-474. 10.1038/ng0497supp-417 9140409
8. Jain AN Chin K Borresen-Dale AL Erikstein BK Eynstein Lonning P Kaaresen R Gray JW Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival Proc Natl Acad Sci USA 2001, 98:7952-7957. 35449 11438741 10.1073/pnas.151241198
9. Naylor TL Greshock J Wang Y Colligon T Yu QC Clemmer V Zaks TZ Weber BL High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization Breast Cancer Res 2005, 7:R1186-1198. 1410746 16457699 10.1186/bcr1356
10. Korsching E Packeisen J Helms MW Kersting C Voss R van Diest PJ Brandt B Wall van der E Boecker W Burger H Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry Br J Cancer 2004, 90:1422-1428. 10.1038/ sj.bjc.6601658 15054466
11. Lichun Y Ching Tang CM Wai Lau K Lung ML Frequent loss of heterozygosity on chromosome 9 in Chinese esophageal squamous cell carcinomas Cancer Lett 2004, 203:71-77. 10.1016/j.canlet.2003.09.027 14670619
12. Simoneau M LaRue H Aboulkassim TO Meyer F Moore L Fradet Y Chromosome 9 deletions and recurrence of superficial bladder cancer: Identification of four regions of prognostic interest Oncogene 2000, 19:6317-6323. 10.1038/sj.onc.1204022 11175346
13. Simoneau M Aboulkassim TO LaRue H Rousseau F Fradet Y Four tumor suppressor loci on chromosome 9q in bladder cancer: Evidence for two novel candidate regions at 9q22.3 and 9q31 Oncogene 1999, 18:157-163. 10.1038/sj.onc.1202277 9926930
14. Nowakowska B Kutkowska-Kazmierczak A Stankiewicz P Bocian E Obersztyn E Ou Z Cheung SW Cai WW A girl with deletion 9q22.1-q22.32 including the PTCH and ROR2 genes identified by genome-wide array-CGH Am J Med Genet A 2007, 143A:1885-1889. 10.1002/ajmg.a.31845 17632781
15. D'Alessandro M Coats SE Morley SM Mackintosh L Tessari G Turco A Gerdes AM Pichert G Whittaker S Brandrup F et al. Multiple self-healing squamous epithelioma in different ethnic groups: More than a founder mutation disorder? J Invest Dermatol 2007, 127:2336-2344. 10.1038/ sj.jid.5700914 17554363
16. Wreesmann VB Estilo C Eisele DW Singh B Wang SJ Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma ORL J Otorhinolaryngol Relat Spec 2007, 69:218-225. 17409780
17. Haneline LS Gobbett TA Ramani R Carreau M Buchwald M Yoder MC Clapp DW Loss of FancC function results in decreased hematopoietic stem cell repopulating ability Blood 1999, 94:1-8. 10381491
18. Habi O Delisle MC Messier N Carreau M Lack of self-renewal capacity in Fancc-/- stem cells after ex vivo expansion Stem Cells 2005, 23:1135-1141. 10.1634/stemcells.2004-0356 16020692
19. Kitao H Yamamoto K Matsushita N Ohzeki M Ishiai M Takata M Functional interplay between BRCA2/FancD1 and FancC in DNA repair J Biol Chem 2006, 281:21312-21320. 10.1074/jbc.M603290200 16687415
20. Neveling K Kalb R Florl AR Herterich S Friedl R Hoehn H Hader C Hartmann FH Nanda I Steinlein C et al. Disruption of the FA/BRCA pathway in bladder cancer Cytogenet Genome Res 2007, 118:166-176. 10.1159/000108297 18000367
21. Heijden van der MS Yeo CJ Hruban RH Kern SE Fanconi anemia gene mutations in young-onset pancreatic cancer Cancer Res 2003, 63:2585-2588. 12750283
22. Couch FJ Johnson MR Rabe K Boardman L McWilliams R de Andrade M Petersen G Germ line Fanconi anemia complementation group C mutations and pancreatic cancer Cancer Res 2005, 65:383-386. 15695377
23. Shahi MH Lorente A Castresana JS Hedgehog signalling in medulloblastoma, glioblastoma and neuroblastoma Oncol Rep 2008, 19:681-688. 18288402
24. Reifenberger J Arnold N Kiechle M Reifenberger G Hauschild A Coincident PTCH and BRCA1 germline mutations in a patient with nevoid basal cell carcinoma syndrome and familial breast cancer J Invest Dermatol 2001, 116:472-474. 11231326
25. Adolphe C Hetherington R Ellis T Wainwright B Patched1 functions as a gatekeeper by promoting cell cycle progression Cancer Res 2006, 66:2081-2088. 10.1158/0008-5472.CAN-05-2146 16489008
26. Wolf I Bose S Desmond JC Lin BT Williamson EA Karlan BY Koeffler HP Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer Breast Cancer Res Treat 2007, 105:139-155. 10.1007/s10549-006-9440-4 17295047
27. Asahina H Kuraoka I Shirakawa M Morita EH Miura N Miyamoto I Ohtsuka E Okada Y Tanaka K The XPA protein is a zinc metalloprotein with an ability to recognize various kinds of DNA damage Mutat Res 1994, 315:229-237. 7526200
28. Kuraoka I Morita EH Saijo M Matsuda T Morikawa K Shirakawa M Tanaka K Identification of a damaged-DNA binding domain of the XPA protein Mutat Res 1996, 362:87-95. 8538652
29. Patrick SM Turchi JJ Xeroderma pigmentosum complementation group A protein (XPA) modulates RPA-DNA interactions via enhanced complex stability and inhibition of strand separation activity J Biol Chem 2002, 277:16096-16101. 10.1074/jbc.M200816200 11859086
30. Miller KL Karagas MR Kraft P Hunter DJ Catalano PJ Byler SH Nelson HH XPA, haplotypes, and risk of basal and squamous cell carcinoma Carcinogenesis 2006, 27:1670-1675. 10.1093/carcin/bgi376 16513681
31. Wang Y Spitz MR Lee JJ Huang M Lippman SM Wu X Nucleotide excision repair pathway genes and oral premalignant lesions Clin Cancer Res 2007, 13:3753-3758. 10.1158/1078-0432.CCR-06-1911 17575242
32. Takebayashi Y Nakayama K Kanzaki A Miyashita H Ogura O Mori S Mutoh M Miyazaki K Fukumoto M Pommier Y Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors Cancer Lett 2001, 174:115-125. 10.1016/S0304-3835(01)00690-5 11689286
33. Hasenpusch-Theil K Chadwick BP Theil T Heath SK Wilkinson DG Frischauf AM PHF2, a novel PHD finger gene located on human chromosome 9q22 Mamm Genome 1999, 10:294-298. 10.1007/s003359900989 10051327
34. Sobin LH Wittekind C TNM Classification of Malignant Tumors New York: Wiley 6 2002
35. Dasgupta S Mukherjee N Roy S Roy A Sengupta A Roychowdhury S Panda CK Mapping of the candidate tumor suppressor genes' loci on human chromosome 3 in head and neck squamous cell carcinoma of an Indian patient population Oral Oncol 2002, 38:6-15. 10.1016/ S1368-8375(00)00131-7 11755815
36. Tripathi Bhar A Banerjee S Chunder N Roy A Sengupta A Roy B Roychowdhury S Panda CK Differential alterations of the genes in the CDKN2A-CCND1-CDK4-RB1 pathway are associated with the development of head and neck squamous cell carcinoma in Indian patients J Cancer Res Clin Oncol 2003, 129:642-650. 10.1007/s00432-003-0485-z 14586645
37. Ichimura K Bolin MB Goike HM Schmidt EE Moshref A Collins VP Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities Cancer Res 2000, 60:417-424. 10667596
38. Loginov VI Maliukova AV Seregin Iu A Khodyrev DS Kazubskaia TP Ermilova VD Gar'kavtseva RF Kiselev LL Zabarovskii ER Braga EA [Methylation of the promoter region of the RASSF1A gene, a candidate tumor suppressor, in primary epithelial tumors] Mol Biol (Mosk) 2004, 38:654-667. 15456137
39. Ivanova T Petrenko A Gritsko T Vinokourova S Eshilev E Kobzeva V Kisseljov F Kisseljova N Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer BMC Cancer 2002, 2:4. 101392 11945179 10.1186/1471-2407-2-4
40. Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001, 25:402-408. 10.1006/meth.2001.1262 11846609
41. Milde-Langosch K Bamberger AM Rieck G Kelp B Loning T Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype Breast Cancer Res Treat 2001, 67:61-70. 10.1023/ A:1010623308275 11518467
42. Chunder N Mandal S Roy A Roychoudhury S Panda CK Differential association of BRCA1 and BRCA2 genes with some breast cancer-associated genes in early and late onset breast tumors Ann Surg Oncol 2004, 11:1045-1055. 10.1245/ASO.2004.02.022 15576832
43. Mizuno T Tokuoka S Kishikawa M Nakashima E Mabuchi K Iwamoto KS Molecular basis of basal cell carcinogenesis in the atomic-bomb survivor population: P53 and PTCH gene alterations Carcinogenesis 2006, 27:2286-2294. 10.1093/carcin/bgl107 16777989